Notice Number: NOT-GM-17-020
Key Dates
Release Date: August 25, 2017
Issued by
National Institute of General Medical Sciences (NIGMS)
Purpose
The purpose of this Notice is to clarify the scoring procedures for applications submitted to PAR-17-190 "Maximizing Investigators' Research Award for Early Stage Investigators (R35)". Similar to previous FOAs for the MIRA program, reviewers will consider each of the review criteria in the determination of scientific merit but will not give a separate score for each. Accordingly, the following section of the FOA has been updated as indicated below.
Current language:
Reviewers will consider each of the review criteria below in the determination of scientific merit. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a program that by its nature is not innovative may be essential to advance a field.
Clarified language:
Reviewers will consider each of the review criteria below in the determination of scientific merit, but will not give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a program that by its nature is not innovative may be essential to advance a field.
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Kristine Willis, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Telephone: 301-594-0943
Email: [email protected]